Geneos Wealth Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-270
| Closed | -$14K | – | 2396 |
|
|
2022
Q2 | $14K | Buy |
270
+20
| +8% | +$1.04K | ﹤0.01% | 1838 |
|
|
2022
Q1 | $18K | Sell |
250
-917
| -79% | -$66K | ﹤0.01% | 1860 |
|
|
2021
Q4 | $137K | Hold |
1,167
| – | – | 0.01% | 1050 |
|
|
2021
Q3 | $156K | Hold |
1,167
| – | – | 0.01% | 967 |
|
|
2021
Q2 | $191K | Buy |
1,167
+250
| +27% | +$40.9K | 0.01% | 866 |
|
|
2021
Q1 | $70K | Hold |
917
| – | – | ﹤0.01% | 1455 |
|
|
2020
Q4 | $73K | Sell |
917
-2
| -0.2% | -$159 | ﹤0.01% | 1270 |
|
|
2020
Q3 | $19K | Buy |
919
+2
| +0.2% | +$41 | ﹤0.01% | 1676 |
|
|
2020
Q2 | $18K | Hold |
917
| – | – | ﹤0.01% | 1668 |
|
|
2020
Q1 | $10K | Buy |
+917
| New | +$10K | ﹤0.01% | 1821 |
|
|
2019
Q4 | – | Sell |
-917
| Closed | -$12K | – | 2566 |
|
|
2019
Q3 | $12K | Hold |
917
| – | – | ﹤0.01% | 1808 |
|
|
2019
Q2 | $15K | Hold |
917
| – | – | ﹤0.01% | 1766 |
|
|
2019
Q1 | $15K | Hold |
917
| – | – | ﹤0.01% | 1700 |
|
|
2018
Q4 | $11K | Buy |
+917
| New | +$11K | ﹤0.01% | 1753 |
|